NCT05822154

Brief Summary

The primary objective of this observational study is to verify, through a comprehensive geriatric assessment, the health status of a sample of elderly subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

June 23, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

March 27, 2023

Last Update Submit

June 22, 2023

Conditions

Keywords

ageingcomprehensive geriatric assessmentpolypharmacy

Outcome Measures

Primary Outcomes (2)

  • Change in health conditions

    The prevalence of comorbidities and their risk factors at time of enrolment

    Baseline, 3, 6 and 12 months later

  • Change in prevalence of polypharmacy

    Number of participants with polypharmacy. Polypharmacy will be defined as being on five or more medications at one time

    Baseline, 3, 6 and 12 months later

Secondary Outcomes (5)

  • Change in frailty condition

    Baseline, 3, 6 and 12 months later

  • Change in functional capacity

    Baseline, 3, 6 and 12 months later

  • Change in functional capacity

    Baseline, 3, 6 and 12 months later

  • Change in physical performance

    Baseline, 3, 6 and 12 months later

  • Change of cognitive function score

    Baseline, 3, 6 and 12 months late

Study Arms (1)

elderly subjects

subjects aged 65 years and over

Other: comprehensive geriatric assessment

Interventions

The clinical, biological and functional characteristics will be collected in elderly subjects attending the hospitals of participating centers.

elderly subjects

Eligibility Criteria

Age65 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients from different settings (inpatients and outpatients) who attend the hospitals of the participating centres.

You may qualify if:

  • subjects with 65 years or older

You may not qualify if:

  • no informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS INRCA Hospital

Cosenza, Italy

RECRUITING

MeSH Terms

Conditions

Frailty

Interventions

Geriatric Assessment

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth StatusDemographyPopulation CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Andrea Corsonello, MD

    IRCCS INRCA, Cosenza, Italy

    PRINCIPAL INVESTIGATOR
  • Simona Ciccone, MD

    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

    PRINCIPAL INVESTIGATOR
  • Antonio Greco, MD

    Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

    PRINCIPAL INVESTIGATOR
  • Rodolfo Sardone, MD

    IRCCS "Saverio de Bellis", Castellana Grotte (BA), Italy

    PRINCIPAL INVESTIGATOR
  • Fabrizio Giunco, MD

    Fondazione Don Carlo Gnocchi, Milano, Italy

    PRINCIPAL INVESTIGATOR
  • Mariacristina Parravano, MD

    Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia, Roma, Italy

    PRINCIPAL INVESTIGATOR
  • Marco Lenti, MD

    Fondazione Policlinico San Matteo, Pavia, Italy

    PRINCIPAL INVESTIGATOR
  • Rosa Liperoti, MD

    Fondazione Policlinico Universitario A. Gemelli, Roma, Italy

    PRINCIPAL INVESTIGATOR
  • Francesca Bruni, MD

    Istituto Auxologico Italiano, Milano, Italy

    PRINCIPAL INVESTIGATOR
  • Giuseppe Rengo, MD

    Istituti Clinici Scientifici Maugeri, Scientific Institute of Telese Terme (BN), Italy

    PRINCIPAL INVESTIGATOR
  • Milena Fini, MD

    Istituto Ortopedico Rizzoli, Bologna, Italy

    PRINCIPAL INVESTIGATOR
  • Luigi Zagra, MD

    Istituto Ortopedico Galeazzi, Milano, Italy

    PRINCIPAL INVESTIGATOR
  • Alessandro Nobili, MD

    Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anna Rita Bonfigli, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2023

First Posted

April 20, 2023

Study Start

October 3, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

June 23, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations